Clinical Trial Update: A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD) [Phase 1]

View source ↗

Summary

AIR-001 is a Phase 1 study in adults with Alpha-1 Antitrypsin Deficiency and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• AIR-001

Snippet

Sponsor: AIRNA Corporation | Conditions: Alpha 1 Antitrypsin Deficiency | Phase 1 | Status: RECRUITING